Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
β Scribed by Parks, R J; Evelegh, C M; Graham, F L
- Book ID
- 110038502
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 125 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0969-7128
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Clinical studies have shown that gene therapy is a promising approach for treating such genetic diseases as the eye disease, Leber's congenital amaurosis. Development of gene therapy approaches for treating chronic inflammatory diseases is, however, more challenging becau
## Abstract ## Background Helperβdependent adenoviral vectors (HDAd) can mediate longβterm phenotypic correction in the ornithine transacarbamylase (OTC)βdeficient mice model with negligible chronic toxicity. However, the high doses required for metabolic correction will result in systemic inflamm